| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $311.3M | — | +126.8% |
| R&D Expense | $108.7M | — | +146.1% |
| SG&A Expense | $268.5M | — | +60.0% |
| Operating Income | -$92.7M | — | -16.9% |
| Net Income | -$94.4M | — | -28.9% |
| EPS (Basic) | -$3.25 | — | +2.1% |
| EPS (Diluted) | -$3.25 | — | +2.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $227.0M | +14.3% | +23.6% |
| Accounts Receivable | $187.4M | +39.3% | +205.0% |
| Inventory | $112.1M | +49.7% | +102.9% |
| Current Assets | $1.18B | -5.1% | +19.7% |
| Total Assets | $1.23B | -2.6% | +23.1% |
| Current Liabilities | $338.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$167.4M | — | -88.4% |
| Capital Expenditures | $3.8M | — | — |
| Investing Cash Flow | $192.2M | — | +17.3% |
| Financing Cash Flow | $2.3M | — | -73.0% |
| Free Cash Flow | -$171.3M | — | -92.7% |
| +102.3% |
| Long-term Debt | $340.3M | +0.1% | +188.4% |
| Total Liabilities | $683.9M | +4.1% | +139.1% |
| Stockholders' Equity | $543.5M | -9.8% | -23.5% |